Surgery Partners (Surgery Partners) EBITDA Margin % : 18.02% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Surgery Partners's EBITDA for the three months ended in Dec. 2023 was $133 Mil. Surgery Partners's Revenue for the three months ended in Dec. 2023 was $735 Mil. Therefore, Surgery Partners's EBITDA margin for the quarter that ended in Dec. 2023 was 18.02%.

Surgery Partners EBITDA Margin % Historical Data

The historical data trend for Surgery Partners's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgery Partners EBITDA Margin % Chart

Surgery Partners Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

16.93

14.93

18.02

18.12

16.26

Surgery Partners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial															17.51	12.02	18.27	16.54	18.02

Competitive Comparison of Surgery Partners's EBITDA Margin %

For the Medical Care Facilities subindustry, Surgery Partners's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgery Partners's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Surgery Partners's EBITDA Margin % falls into.

Surgery Partners EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Surgery Partners's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	446.1	/	2743.3
	=	16.26 %

Surgery Partners's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	132.5	/	735.4
	=	18.02 %

Surgery Partners (NAS:SGRY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Surgery Partners EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Surgery Partners's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgery Partners (Surgery Partners) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027

Website

https://www.surgerypartners.com

Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.

Executives

Bain Capital Investors Llc	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt	director, officer: Chief Executive Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
T. Devin O'reilly	director, 10 percent owner	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix	director, 10 percent owner
Andrew T. Kaplan	director	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Jason Eric Evans	officer: EVP & Chief Operating Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane	officer: American Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty	officer: Chief Financial Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bradley R. Owens	officer: National Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter	officer: Chief Human Resources Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo	officer: President, Atlantic Group	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock	officer: Sr. VP, Gen Couns. & Sec.	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham	officer: Chief Strategy Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Fund Xi, L.p.	director, 10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Xi, L.p.	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116